Croda International plc published a transcript of its full-year 2025 results call (for the 12 months ended 31 December 2025), held on 24 February 2026. The call was attended by Group Chief Executive Steve Foots, Chief Financial Officer Stephen Oxley and Director of Investor Relations David Bishop, alongside analysts including UBS, Morgan Stanley, Berenberg, Barclays, Bank of America, JP Morgan, Citi, Deutsche Bank and Exane BNP Paribas. Management reported 7% constant-currency sales growth to £1.7bn and an 8% rise in adjusted operating profit to £295m, with adjusted PBT up 8% to £276m. Croda highlighted improving momentum in Consumer Care and Life Sciences, better second-half free cash flow, and early benefits from its transformation programme, while also detailing significant exceptional charges and an impairment tied to its US pharma lipids facility in Lamar, which has been placed on standby. “We're pleased with how the business has performed in an uncertain environment,” Foots said, adding that “our actions are bearing fruit.” Oxley said Croda expects 2026 adjusted operating profit “to be in line with current market expectations,” with 3-6% organic sales growth and “a further increase in operating margin.” He also set out medium-term targets, including lifting adjusted operating margin from 17.4% in 2025 to “more than 20% for full year 2028,” supported by “total annualised savings of £100m” and a £50m working-capital reduction by 2028. On the Lamar site, Oxley stressed, “we've put it on standby… ready to fire it up at short notice,” while Foots said Croda has “adequate capacity to meet the near-term and medium-term demand.” The full transcript can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Croda International plc published the original content used to generate this news brief on February 25, 2026, and is solely responsible for the information contained therein.
Comments